MDT

99.78

+0.07%↑

A

146.88

+0.33%↑

VEEV

243.22

+1.79%↑

HQY

97.62

+0.6%↑

PHR.US

16.87

-3.16%↓

MDT

99.78

+0.07%↑

A

146.88

+0.33%↑

VEEV

243.22

+1.79%↑

HQY

97.62

+0.6%↑

PHR.US

16.87

-3.16%↓

MDT

99.78

+0.07%↑

A

146.88

+0.33%↑

VEEV

243.22

+1.79%↑

HQY

97.62

+0.6%↑

PHR.US

16.87

-3.16%↓

MDT

99.78

+0.07%↑

A

146.88

+0.33%↑

VEEV

243.22

+1.79%↑

HQY

97.62

+0.6%↑

PHR.US

16.87

-3.16%↓

MDT

99.78

+0.07%↑

A

146.88

+0.33%↑

VEEV

243.22

+1.79%↑

HQY

97.62

+0.6%↑

PHR.US

16.87

-3.16%↓

Search

Stevanato Group SpA

Aperta

SettoreSettore sanitario

21.49 0.33

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

21.44

Massimo

21.88

Metriche Chiave

By Trading Economics

Entrata

10M

49M

Vendite

23M

303M

P/E

Media del settore

35.083

87.826

EPS

0.162

Rendimento da dividendi

0.26

Margine di Profitto

16.205

Dipendenti

5,521

EBITDA

10M

73M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+24.02% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

0.26%

2.26%

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-991M

5.7B

Apertura precedente

21.16

Chiusura precedente

21.49

Notizie sul Sentiment di mercato

By Acuity

50%

50%

166 / 372 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Weak Bullish Evidence

Stevanato Group SpA Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

7 gen 2026, 23:11 UTC

Utili

Samsung Electronics Expects Record Fourth-Quarter Profit Beat

7 gen 2026, 22:55 UTC

I principali Market Mover

Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027

7 gen 2026, 21:39 UTC

I principali Market Mover

Raytheon Down Following Trump Post Criticizing Company

7 gen 2026, 20:13 UTC

I principali Market Mover

AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition

7 gen 2026, 20:03 UTC

I principali Market Mover

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay

7 gen 2026, 23:46 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

7 gen 2026, 23:46 UTC

Discorsi di Mercato

Nikkei May Decline as China-Japan Tensions Linger -- Market Talk

7 gen 2026, 23:42 UTC

Acquisizioni, Fusioni, Takeovers

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update

7 gen 2026, 23:34 UTC

Discorsi di Mercato

Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk

7 gen 2026, 23:29 UTC

Acquisizioni, Fusioni, Takeovers

Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com

7 gen 2026, 22:48 UTC

Discorsi di Mercato

Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk

7 gen 2026, 22:46 UTC

Utili

Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE

7 gen 2026, 22:45 UTC

Utili

Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE

7 gen 2026, 22:43 UTC

Acquisizioni, Fusioni, Takeovers

Revolution Medicines Draws Takeover Interest -- 2nd Update

7 gen 2026, 22:42 UTC

Utili

Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast

7 gen 2026, 22:41 UTC

Utili

Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE

7 gen 2026, 22:41 UTC

Utili

Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE

7 gen 2026, 22:40 UTC

I principali Market Mover

Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027

7 gen 2026, 22:31 UTC

Discorsi di Mercato

Macro Tailwinds Strengthen for Chalice Mining -- Market Talk

7 gen 2026, 22:22 UTC

Discorsi di Mercato

Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk

7 gen 2026, 22:01 UTC

Discorsi di Mercato

Valuations of New Zealand Property Stocks Supportive -- Market Talk

7 gen 2026, 21:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

7 gen 2026, 21:46 UTC

Discorsi di Mercato

Northern Star's Revised Guidance Looks Achievable -- Market Talk

7 gen 2026, 21:22 UTC

Acquisizioni, Fusioni, Takeovers

Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX

7 gen 2026, 21:18 UTC

Acquisizioni, Fusioni, Takeovers

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX

7 gen 2026, 21:05 UTC

Acquisizioni, Fusioni, Takeovers

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update

7 gen 2026, 20:29 UTC

Acquisizioni, Fusioni, Takeovers

AbbVie Near Deal for Revolution Medicines -- Update

7 gen 2026, 20:27 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

7 gen 2026, 19:58 UTC

Discorsi di Mercato

Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk

7 gen 2026, 19:48 UTC

I principali Market Mover

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay

Confronto tra pari

Modifica del prezzo

Stevanato Group SpA Previsione

Obiettivo di Prezzo

By TipRanks

24.02% in crescita

Previsioni per 12 mesi

Media 27 USD  24.02%

Alto 30 USD

Basso 24 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Stevanato Group SpA - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

3 ratings

2

Acquista

1

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

21.56 / 22.61Supporto e resistenza

A breve termine

Weak Bullish Evidence

A termine intermedio

Weak Bearish Evidence

A lungo termine

Bullish Evidence

Sentiment

By Acuity

166 / 372 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Stevanato Group SpA

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
help-icon Live chat